Cargando…

Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma

PURPOSE: Patients with cancers of oropharynx have a favorable prognosis and are an ideal candidate for adaptive therapy. A replan to improve coverage or escalate/de-escalate dose based on morphological information alone may not be adequate as the grossly involved lymph nodes (LNs) of a subset of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyagi, Neelam, Riaz, Nadeem, Hunt, Margie, Wengler, Kenneth, Hatzoglou, Vaios, Young, Robert, Mechalakos, James, Lee, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Physicists in Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360161/
https://www.ncbi.nlm.nih.gov/pubmed/26745906
http://dx.doi.org/10.1118/1.4937791
_version_ 1782516543521816576
author Tyagi, Neelam
Riaz, Nadeem
Hunt, Margie
Wengler, Kenneth
Hatzoglou, Vaios
Young, Robert
Mechalakos, James
Lee, Nancy
author_facet Tyagi, Neelam
Riaz, Nadeem
Hunt, Margie
Wengler, Kenneth
Hatzoglou, Vaios
Young, Robert
Mechalakos, James
Lee, Nancy
author_sort Tyagi, Neelam
collection PubMed
description PURPOSE: Patients with cancers of oropharynx have a favorable prognosis and are an ideal candidate for adaptive therapy. A replan to improve coverage or escalate/de-escalate dose based on morphological information alone may not be adequate as the grossly involved lymph nodes (LNs) of a subset of these patients tend to become cystic and often do not regress. Functional adaptation may be a better approach when considering replanning for these patients. The purpose of this study was to evaluate the weekly trends in treatment related morphological and physiological changes for these LNs using diffusion-weighted MRI (DW-MRI) and evaluate its implications for adaptive replanning. METHODS: Ten patients with histologically proven oropharynx HNSCC undergoing concurrent chemoradiation were analyzed in this study. MR imaging protocol included axial T1w, T2w, and DW-MRI using a 3 T Philips MR scanner. The patients were scanned weekly in radiation treatment planning position using a 16 element phased-array anterior coil and a 44 element posterior coil. A total of 65 DWI and T2w scans were analyzed. DWI was performed using an optimized single-shot echo planar imaging sequence (TR/TE = 5000/65 ms, slice thickness = 5 mm; slices = 28; b values = 0 and 800 s/mm(2)). Quantification of the DW-MRI images was performed by calculating the apparent diffusion coefficient (ADC). T2w and DWI scans were imported into the Eclipse treatment planning system and gross tumor volumes (GTVs) corresponding to grossly involved LNs were contoured on each axial slice by physician experts. An attempt was made to remove any cystic or necrotic components so that the ADC analysis was of viable tumor only. A pixel-by-pixel fit of signal intensities within the GTVs was performed assuming monoexponential behavior. From each GTV histogram mean, median, standard deviation, skewness, and kurtosis were calculated. Absolute and percent change in weekly ADC histogram parameters and percent change in T2w GTV were also calculated. RESULTS: For all nodes, an immediate change in ADC was observed during first 2–3 weeks after which ADC values either continued to increase or plateaued. A few nodal volumes had a slightly decreased ADC value during later weeks. Percent increase in median ADC from weeks 1 to 6 with respect to baseline was 14%, 25%, 41%, 42%, 45%, and 58%. The corresponding change in median T2 volumes was 8%, 10%, 16%, 22%, 40%, and 42%, respectively. The ADC distribution of the viable tumors was initially highly kurtotic; however, the kurtosis decreased as treatment progressed. The ADC distribution also showed a higher degree of skewness in the first 2 weeks, progressively becoming less skewed as treatment progressed so as to slowly approach a more symmetric distribution. CONCLUSIONS: Physiological changes in LNs represented by changes in ADC evaluated using DW-MRI are evident sooner than the morphological changes calculated from T2w MRI. The decisions for adaptive replanning may need to be individualized and should be based primarily on tumor functional information. The authors’ data also suggest that for many patients, week 3 maybe the optimal time to intervene and replan. Larger studies are needed to confirm their findings.
format Online
Article
Text
id pubmed-5360161
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Association of Physicists in Medicine
record_format MEDLINE/PubMed
spelling pubmed-53601612017-03-31 Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma Tyagi, Neelam Riaz, Nadeem Hunt, Margie Wengler, Kenneth Hatzoglou, Vaios Young, Robert Mechalakos, James Lee, Nancy Med Phys THERAPEUTIC INTERVENTIONS PURPOSE: Patients with cancers of oropharynx have a favorable prognosis and are an ideal candidate for adaptive therapy. A replan to improve coverage or escalate/de-escalate dose based on morphological information alone may not be adequate as the grossly involved lymph nodes (LNs) of a subset of these patients tend to become cystic and often do not regress. Functional adaptation may be a better approach when considering replanning for these patients. The purpose of this study was to evaluate the weekly trends in treatment related morphological and physiological changes for these LNs using diffusion-weighted MRI (DW-MRI) and evaluate its implications for adaptive replanning. METHODS: Ten patients with histologically proven oropharynx HNSCC undergoing concurrent chemoradiation were analyzed in this study. MR imaging protocol included axial T1w, T2w, and DW-MRI using a 3 T Philips MR scanner. The patients were scanned weekly in radiation treatment planning position using a 16 element phased-array anterior coil and a 44 element posterior coil. A total of 65 DWI and T2w scans were analyzed. DWI was performed using an optimized single-shot echo planar imaging sequence (TR/TE = 5000/65 ms, slice thickness = 5 mm; slices = 28; b values = 0 and 800 s/mm(2)). Quantification of the DW-MRI images was performed by calculating the apparent diffusion coefficient (ADC). T2w and DWI scans were imported into the Eclipse treatment planning system and gross tumor volumes (GTVs) corresponding to grossly involved LNs were contoured on each axial slice by physician experts. An attempt was made to remove any cystic or necrotic components so that the ADC analysis was of viable tumor only. A pixel-by-pixel fit of signal intensities within the GTVs was performed assuming monoexponential behavior. From each GTV histogram mean, median, standard deviation, skewness, and kurtosis were calculated. Absolute and percent change in weekly ADC histogram parameters and percent change in T2w GTV were also calculated. RESULTS: For all nodes, an immediate change in ADC was observed during first 2–3 weeks after which ADC values either continued to increase or plateaued. A few nodal volumes had a slightly decreased ADC value during later weeks. Percent increase in median ADC from weeks 1 to 6 with respect to baseline was 14%, 25%, 41%, 42%, 45%, and 58%. The corresponding change in median T2 volumes was 8%, 10%, 16%, 22%, 40%, and 42%, respectively. The ADC distribution of the viable tumors was initially highly kurtotic; however, the kurtosis decreased as treatment progressed. The ADC distribution also showed a higher degree of skewness in the first 2 weeks, progressively becoming less skewed as treatment progressed so as to slowly approach a more symmetric distribution. CONCLUSIONS: Physiological changes in LNs represented by changes in ADC evaluated using DW-MRI are evident sooner than the morphological changes calculated from T2w MRI. The decisions for adaptive replanning may need to be individualized and should be based primarily on tumor functional information. The authors’ data also suggest that for many patients, week 3 maybe the optimal time to intervene and replan. Larger studies are needed to confirm their findings. American Association of Physicists in Medicine 2016-01 2015-12-22 /pmc/articles/PMC5360161/ /pubmed/26745906 http://dx.doi.org/10.1118/1.4937791 Text en © 2016 American Association of Physicists in Medicine. 0094-2405/2016/43(1)/137/11/$30.00 All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle THERAPEUTIC INTERVENTIONS
Tyagi, Neelam
Riaz, Nadeem
Hunt, Margie
Wengler, Kenneth
Hatzoglou, Vaios
Young, Robert
Mechalakos, James
Lee, Nancy
Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma
title Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma
title_full Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma
title_fullStr Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma
title_full_unstemmed Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma
title_short Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma
title_sort weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted mri in oropharynx squamous cell carcinoma
topic THERAPEUTIC INTERVENTIONS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360161/
https://www.ncbi.nlm.nih.gov/pubmed/26745906
http://dx.doi.org/10.1118/1.4937791
work_keys_str_mv AT tyagineelam weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT riaznadeem weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT huntmargie weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT wenglerkenneth weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT hatzoglouvaios weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT youngrobert weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT mechalakosjames weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma
AT leenancy weeklyresponseassessmentofinvolvedlymphnodestoradiotherapyusingdiffusionweightedmriinoropharynxsquamouscellcarcinoma